NCT01388621 Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT01387399 Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer Status UNKNOWN Phase PHASE1
NCT01383408 Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection Status TERMINATED Phase PHASE2
NCT01379989 INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01376505 Vaccine Therapy in Treating Patients With Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01370122 Pelvic Floor Disorders in Survivors of Gynecologic Malignancies Status COMPLETED Phase N/A
NCT01358071 Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01357161 A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) Status COMPLETED Phase PHASE2
NCT01312389 A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01309230 A Trial of FANG™ Vaccine for Participants With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01284075 The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery Status TERMINATED Phase NA